Gabrielli, O <br/><br/>
Atenolol improves ventricular function without changing plasma noradrenaline but decreasing plasma atrial natriuretic factor in chronic heart failure.  [electronic resource] 

 -  Autonomic & autacoid pharmacology   
 - 261-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-8665 
<br/><br/><label>Standard No.: </label>10.1046/j.1474-8673.2002.00266.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Atenolol--therapeutic use<br/>Atrial Natriuretic Factor--blood<br/>Blood Pressure--drug effects<br/>Cardiomyopathy, Dilated--complications<br/>Catecholamines--blood<br/>Chronic Disease<br/>Electrocardiography, Ambulatory<br/>Ergometry<br/>Exercise--physiology<br/>Female<br/>Heart--drug effects<br/>Heart Failure--blood<br/>Heart Rate--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Norepinephrine--blood<br/>Sympathetic Nervous System--drug effects<br/>Ventricular Function, Left--drug effects